Can You Get Mounjaro on the NHS — and What Happens If You Can't?

You've looked into Mounjaro and found out the NHS offers it, here's the part most people miss

NICE recommended tirzepatide for NHS use in December 2024, which was genuinely significant news. The trouble is that a NICE recommendation and immediate NHS access are two different things. NHS England is commissioning the treatment in phases, and the criteria for each phase are deliberately tight.

Right now, the first cohort requires a BMI of 40 or above plus four or more qualifying conditions from a specific list: high blood pressure, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, and type 2 diabetes. That combination is rare. Most people who are a healthy weight candidate for Mounjaro simply do not carry four of those five diagnoses simultaneously. The exact NHS eligibility conditions are spelled out in full if you want to check each one against your own medical history.

A second cohort opened in June 2026, covering people with a BMI between 35 and 39.9 plus the same four-condition requirement. A third cohort, reducing the condition count to three, is expected around March 2027. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. So the window is widening, but slowly. When the NHS expects each phase to open is a reasonable thing to look up now, so you're not caught out later.

One more practical point: from April 2026 some GP practices can prescribe Mounjaro under the new GP contract, but participation is voluntary. Your practice may or may not be taking part. Even if you meet the criteria, there is no automatic entitlement, you still need to go through the process.

What the private route actually involves, and whether it's the same medicine

It is exactly the same medicine. Mounjaro dispensed privately comes from the same licensed UK supply chain, in the same KwikPen format, made by Eli Lilly. The difference is not the drug, it's who pays for the assessment and the prescription.

Private prescribing follows the licensed eligibility criteria set out in the medicine's summary of product characteristics, which are broader than the NHS criteria. Adults with a BMI of 30 or above, or 27 or above with at least one weight-related condition such as hypertension or high cholesterol, may be eligible for a private prescription. A prescriber still makes the final call, BMI is a starting point, not a guarantee. If the NHS route is the one you want to pursue, there is a clear set of steps to follow there too.

Through a regulated online pharmacy, the process typically runs: free consultation, clinical review by a GPhC-registered prescriber the same day, identity and weight verification, then prescription and dispatch. Worth checking before you use any online pharmacy: you can look up the pharmacy's registration on the GPhC register in about thirty seconds. If a seller is not listed there, do not use them. The MHRA has warned repeatedly about counterfeit weight-loss pens sold without any clinical oversight, some have contained insulin.

The NHS and private routes are not mutually exclusive. People often start privately, then transition to NHS care once they meet the criteria.

What Mounjaro costs outside the NHS, and how to read a price honestly

This is where the conversation gets uncomfortable, and it's worth being straight about it. Private Mounjaro is not cheap. Following Eli Lilly's UK list-price increase in September 2025, the highest dose's list price rose to around £330 per four-week pen. Actual private prices across the market typically range from about £149 to £375 per month depending on the dose and the provider, as widely reported at the time.

Any legitimate price should include the clinical consultation and prescription, those are not optional extras you bolt on after the fact for a prescription medicine. Some providers charge separately for consultation, prescription, and delivery; others bundle everything. A breakdown of what private Mounjaro costs and what those prices usually cover is worth reading before you compare quotes side by side.

If cost is a barrier, the NHS route remains the right goal, but meeting its criteria requires honest conversations with your GP about your medical history. The NHS criteria are published by NICE and NHS England, so your GP can check your eligibility against them directly. NICE's recommendation for tirzepatide, TA1026, published December 2024, is the document your GP would refer to.

If you don't qualify yet, or can't face another waiting list

Waiting lists for NHS weight management services are long in most parts of England, and private treatment is out of reach for many people at market prices. That is a genuinely frustrating position to be in, and it is one a lot of people find themselves facing.

If private treatment is something you're weighing up, the safest starting point is a structured consultation with a regulated prescriber who will look at the whole picture, your weight, your health history, any medicines you already take, and whether tirzepatide is clinically appropriate for you. Not every applicant is approved, and that is how it should be for a prescription medicine. What buying Mounjaro privately actually involves covers the practical steps clearly. The weight-loss treatment overview is a useful page if you want to compare what is available before committing to anything.

If you'd like a prescriber to review your case today, you can speak to our prescribers through a free consultation, no commitment, no automated screening.